Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Other Accumulated Expenses: 2014-2024

Historic Other Accumulated Expenses for Altimmune (ALT) over the last 6 years, with Dec 2024 value amounting to $55,000.

  • Altimmune's Other Accumulated Expenses rose 227.78% to $177,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $177,000, marking a year-over-year increase of 227.78%. This contributed to the annual value of $55,000 for FY2024, which is 55.65% down from last year.
  • As of FY2024, Altimmune's Other Accumulated Expenses stood at $55,000, which was down 55.65% from $124,000 recorded in FY2023.
  • Altimmune's Other Accumulated Expenses' 5-year high stood at $124,000 during FY2023, with a 5-year trough of $55,000 in FY2024.
  • In the last 3 years, Altimmune's Other Accumulated Expenses had a median value of $103,000 in 2022 and averaged $94,000.
  • Per our database at Business Quant, Altimmune's Other Accumulated Expenses increased by 20.39% in 2023 and then crashed by 55.65% in 2024.
  • Yearly analysis of 3 years shows Altimmune's Other Accumulated Expenses stood at $103,000 in 2022, then increased by 20.39% to $124,000 in 2023, then tumbled by 55.65% to $55,000 in 2024.